Abstract
Objective
Immune response initiation and regulation require activation of dendritic cells (DCs). However, the mechanism by which ferritin, a carrier for immunogen, induces DCs maturation remains unclear.
Results
Recombinant ferritin nanoparticle (RFNp), were prepared through the baculovirus expression vector system, formed spherical and hollow cage-liked proteins with a diameter of approximately 12.17 ± 0.87 nm. They induced bone marrow-derived DC (BMDC) maturation via surface molecules up-regulation of (MHC II, CD80, CD86 and CD40), increased pro-inflammatory cytokines production (IL-6, IL-12, TNF-α, and IFN-γ), and decreased antigen capturing capacity. They positively regulated IκBα and NF-κB (p65) phosphorylation, and facilitate NF-κB (p65) translocation into mature BMDCs nuclei. Following pre-treatment of RFNp-treated BMDCs with TLR4 and NF-κB (p65) inhibitors, respectively, surface molecule expression, pro-inflammatory cytokines production, and IκBα and NF-κB (p65) activities were suppressed. RFNp-treated BMDCs can also facilitate T-cell proliferation and differentiation into Th1 and Th2.
Conclusion
RFNps induced DCs maturation lends the potential application of RFNps as carrier platforms in DC-based vaccine.
Similar content being viewed by others
References
Arima K, Watanabe N, Hanabuchi S, Chang M, Sun SC, Liu YJ (2010) Distinct signal codes generate dendritic cell functional plasticity. Sci Signal 3:ra4
Arosio P, Levi S, Santambrogio P, Cozzi A, Luzzago A, Cesareni G, Albertini A (1991) Structural and functional-studies of human ferritin H-chains and L-chains. Curr Stud Hematol Bl 58:127–131
Cao XX, Li YH, Ye QL, Hua X, Wang TF, Fan MW (2017) Self-assembling anticaries mucosal vaccine containing ferritin cage nanostructure and glucan-binding region of S. mutans glucosyltransferase effectively prevents caries formation in rodents. Hum Vaccin Immunother 13(10):2332–2340
Cho KJ, Shin HJ, Lee JH, Kim KJ, Park SS, Lee Y (2009) The crystal structure of ferritin from Helicobacter pylori reveals unusual conformational changes for iron uptake. J Mol Biol 390:83–98
Han JA, Kang YJ, Shin C, Ra JS, Shin HH, Hong SY, Do Y, Kang S (2014) Ferritin protein cage nanoparticles as versatile antigen delivery nanoplatforms for dendritic cell (DC)-based vaccine development. Nanomedicine: Nanotechnol Biol Med 10:561–569
Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S, Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176:1693–1702
Kanekiyo M, Wei CJ, Yassine HM, McTamney PM, Boyington JC, Whittle JR (2013) Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies. Nature 499:102–106
Kim YS, Son A, Kim J, Kwon SB, Kim MH, Kim P, Kim J, Byun YH, Sung J, Lee J, Yu JE, Park C, Kim YS, Cho NH, Chang J, Seong BL (2018) Chaperna-mediated assembly of ferritin-based middle east respiratory syndrome-coronavirus nanoparticles. Front Immunol 9:1093
Li Z, Cui K, Huang K, Liu F, Shi D, Liu Q (2019) Self-assembling rotavirus VP6 nanoparticle vaccines expressed in Escherichia coli elicit systemic and mucosal responses in mice. Protein Pept Lett 26(12):904–909
Longmire M, Choyke PL, Kobayashi H (2008) Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine 3:703–717
O’Keeffe M, Mok WH, Radford KJ (2015) Human dendritic cell subsets and function in health and disease. Cell Mol Life Sci 72:4309–4325
Panzer R, Blobel C, Folster- Holst R (2014) TLR2 andTLR4 expression in atopic dermatitis, contact dermatitis and psoriasis. Exp Dermatol 23:364–366
Pérez-Betancourt Y, Távora BCLF, Colombini M, Faquim-Mauro EL, Carmona-Ribeiro AM (2020) Simple nanoparticles from the assembly of cationic polymer and antigen as immunoadjuvants. Vaccines (Basel) 8(1):E105
Qu Z, Li M, Guo Y, Liu Y, Wang J, Gao M (2020) Expression, purification, and characterisation of recombinant ferritin in insect cells using the baculovirus expression system. Biotechnol Lett 42:57–65
Reljic R, González-Fernández Á (2019) Nanoparticle vaccines against infectious diseases. Front Immunol 10:2615
Ren M, Gao L, Wu X (2010) TLR4: the receptor bridging Acanthamoeba challenge and intracellular inflammatory responses in human corneal cell lines. Immunol Cell Biol 88:529–536
Taylor PR, Martinez-Pomares L, Stacey M, Lin HH, Brown GD, Gordon S (2005) Macrophage receptors and immune recognition. Annu Rev Immunol 23:901–944
Wang W, Zhou X, Bian Y, Wang S, Chai Q, Guo Z, Wang Z, Zhu P, Peng H, Yan X, Li W, Fu YX, Zhu M (2020) Dual-targeting nanoparticle vaccine elicits a therapeutic antibody response against chronic hepatitis B. Nat Nanotechnol 15:406–416
Yan Y, Wang X, Lou P, Hu Z, Qu P, Li D, Li Q, Xu Y, Niu J, He Y, Zhong J, Zhong H (2020) A nanoparticle-based hepatitis C virus vaccine with enhanced potency. J Infect Dis 221(8):1304–1314
Zhao L, Seth A, Wibowo N, Zhao CX, Mitter N, Yu CZ, Middelberg APJ (2014) Nanoparticle vaccines. Vaccine 32:327–337
Funding
This work was supported by the Agriculture Research System of China (Grant Number CARS-36).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare no financial of commercial conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Qu, Z., Guo, Y., Li, M. et al. Recombinant ferritin nanoparticles can induce dendritic cell maturation through TLR4/NF-κB pathway. Biotechnol Lett 42, 2489–2500 (2020). https://doi.org/10.1007/s10529-020-02944-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10529-020-02944-8